462 Results (Page 19 of 19)
Japan Markets Research Reports
Japan Dental Endodontics Market Analysis
Japan Dental Endodontics Market was valued at $108.80 Mn in 2023 and is predicted to grow at a CAGR of 4.8% from 2023 to 2030, to $151 Mn by 2030. The key drivers of this industry include a focus on oral health, the aging population, and technological advancements. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
Japan Clinical Nutrition Market Analysis
The Japan Clinical Nutrition Market was valued at $1906.4 Mn in 2023 and is projected to grow at a CAGR of 5.84% from 2023 to 2023, to $2836.4 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Otsuka Pharmaceutical, Taisho Pharmaceutical, Kikkoman Corporation, and Ajinomoto, Abbott Nutrition, Nestle, Mead Johnson & Company, LLC among others.
Japan Cancer Induced Bone Diseases Therapeutics Market
Japan Cancer Induced Bone Disease Therapeutics Market valued at $81 Mn in 2022, projected to reach $132 Mn by 2030 with a 6.3% CAGR. The key drivers of this industry include the increasing cancer incidence, technological advancements, and unmet medical needs. The industry is primarily dominated by players such as Daiichi Sankyo, Bayer, Merck, Chugai, Takeda, Novartis, Amgen, and Eisai among others.
Japan Congestive Heart Failure Therapeutics Market Analysis
The Japan Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $640 Mn in 2022 to $1,044 Mn by 2030, with a CAGR of 6.3% during the forecast period of 2022-2030. The primary driving factors include the growing emphasis on quality of life, technological developments in medicine that provide novel therapeutic approaches, and the rising incidence of heart failure as a result of aging populations and sedentary lifestyles in Japan. The Japan Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including Novartis, AstraZeneca, Bayer, Merck, Pfizer, Boehringer Ingelheim, Otsuka, Sumitomo Pharma, Eisai, Meiji Seika Pharma, etc, among various others.
Japan Digital Biomarkers Market Analysis
Japan Digital Biomarkers Market was valued at $180.26 Mn in 2023 and is predicted to grow at a CAGR of 22.8% from 2023 to 2030, to $759.08 Mn by 2030. The key drivers of this industry include the growing prevalence of chronic diseases, the aging population, and the focus on innovation. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Japan Cardiac Resynchronization Therapy Market
Japan Cardiac Resynchronization Therapy Market valued at $298 Mn in 2022, projected to reach $458 Mn by 2030 with a 5.5% CAGR. The global surge in heart failure cases, driven by aging populations and lifestyle-related cardiovascular diseases, is a significant catalyst contributing to the expansion of the Cardiac Resynchronization Therapy (CRT) market. Currently, major contributors to this market include companies such as Abbott, Biotronik, Boston Scientific, Medtronic, Nihon Kohden, Oscor, Siemens Healthineers, Sorin Group, MicroPort CRM, and Osram Health.
Japan Biosensors Market Analysis
The Japan Biosensors Market was valued at $1796.4 Mn in 2023 and is predicted to grow at a CAGR of 8.5% from 2023 to 2030, to $3179.9 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, increasing demand for accurate disease diagnosis, and growing demand for Point-of-Care (POC) testing. The prominent players of the Japan Biosensors Market are Nipro, Terumo Corporation, Abbott Laboratories, Medtronic, Bio-Rad International, Siemens Healthcare, and F. Hoffmann- La Roche, among others.
Japan Physiotherapy Equipment Market Analysis
The Japan Physiotherapy Equipment Market was valued at $1,299.12 Mn in 2023 and is predicted to grow at a CAGR of 7.7% from 2023 to 2030, to $2,183.52 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are Takeda Medical, Fujirebio, Nihon Kohden, and Enraf-Nonius BV among others.
Japan Dental Consumables Market Analysis
The Japan Dental Consumables Market was valued at $2101 Mn in 2023 and is projected to grow at a CAGR of 8.5% from 2023 to 2023, to $3719 Mn by 2030. The key drivers of this industry growing dental care needs, technological advancements, expanding dental infrastructure, increasing disposable incomes, public health initiatives, dental tourism, rising consumption of sugary and starchy foods, rise in unhealthy eating habits due to rising urbanization, changing living standards. The industry is primarily dominated by players such as GC Corporation, Shofu Inc, Kuraray Noritake Dental Inc, Dentsply Sirona, 3M, Sun Medical Co Ltd among others.
Japan Cardiac Arrhythmia Therapeutics Market
Japan Cardiac Arrhythmia Therapeutics Market valued at $448 Mn in 2022, projected to reach $730 Mn by 2030 with a 6.3% CAGR. The key drivers of this industry include the rising prevalence of cardiac arrhythmias, supportive government initiatives, and technological advancements. The industry is primarily dominated by players such as Abbott, Philips Healthcare, Boston Scientific, Olympus, Terumo, and Esaote among others.
Japan Medical Digital Imaging System Market Analysis
The Japan Medical Digital Imaging System Market was valued at $1895.84 Mn in 2023 and is predicted to grow at a CAGR of 8.70% from 2023 to 2030, to $3399.45 Mn by 2030. The key drivers of this industry include an aging population, healthcare infrastructure, and technological advancements. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.
Japan Hemodialysis Vascular Grafts Market Analysis
Japan Hemodialysis Vascular Grafts Market was valued at $13.02 Bn in 2023 and is predicted to grow at a CAGR of 5.6% from 2023 to 2030, to $19.06 Bn by 2030. The key drivers of this industry include an aging population, a high prevalence of ESRD, and government support for healthcare. The industry is primarily dominated by W. L. Gore, C. R. Bard, Vascudyne, and LeMaitre among others.